NeuroSense Therapeutics Ltd. (NRSN) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

NeuroSense Therapeutics Ltd. (NRSN) quarterly cash flow statement — complete operating, investing & financing history

Metric	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22

Cash from Operations	-2K	0	0	0	0	0	0	0	0	0	0	0
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-2.35K	-2.35K	-1.8K	-2.15K	-857	-5.4K	-1.78K	784	-5.22K	-3.89K	-1.3K	-2.99K
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0
Stock-Based Compensation	153	153	557	-306	306	0	1.54K	-1.78K	1.78K	0	1.73K	-2.81K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-30	2.2K	1.24K	2.45K	551	5.4K	240	1K	3.44K	3.89K	-426	5.8K
Working Capital Changes	231	0	0	0	0	0	0	0	0	0	0	0
Change in Receivables	71	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Investing	-7	0	0	0	0	0	0	0	0	0	0	0
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	-7	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	651	0	0	0	0	0	0	0	0	0	0	0
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	651	0	0	0	0	0	0	0	0	0	0	0
Net Change in Cash	-1.36K	0	0	0	0	0	-2.12M	-2.33M	5.73M	-2.18M	-855K	62K
Free Cash Flow	-2K	0	0	0	0	0	0	0	0	0	0	0
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-	-	-	-	-	-	-	-	-	-	-	-
FCF per Share	-0.00	-	-	-	-	-	-	-	-	-	-	-
FCF Conversion (FCF/Net Income)	0.00x	-	-	-	-	-	-	-	-	-	-	-
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0

120+ quarters historyFree accessUpdated daily

NeuroSense Therapeutics Ltd. (NRSN) quarterly cash flow statement — complete operating, investing & financing history

Metric	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22

Cash from Operations	-2K	0	0	0	0	0	0	0	0	0	0	0
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-2.35K	-2.35K	-1.8K	-2.15K	-857	-5.4K	-1.78K	784	-5.22K	-3.89K	-1.3K	-2.99K
Depreciation & Amortization	0	0	0	0	0	0	0	0	0	0	0	0
Stock-Based Compensation	153	153	557	-306	306	0	1.54K	-1.78K	1.78K	0	1.73K	-2.81K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	0
Other Non-Cash Items	-30	2.2K	1.24K	2.45K	551	5.4K	240	1K	3.44K	3.89K	-426	5.8K
Working Capital Changes	231	0	0	0	0	0	0	0	0	0	0	0
Change in Receivables	71	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	0	0	0	0	0	0	0	0	0	0
Cash from Investing	-7	0	0	0	0	0	0	0	0	0	0	0
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	0	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	-7	0	0	0	0	0	0	0	0	0	0	0
Cash from Financing	651	0	0	0	0	0	0	0	0	0	0	0
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	651	0	0	0	0	0	0	0	0	0	0	0
Net Change in Cash	-1.36K	0	0	0	0	0	-2.12M	-2.33M	5.73M	-2.18M	-855K	62K
Free Cash Flow	-2K	0	0	0	0	0	0	0	0	0	0	0
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-	-	-	-	-	-	-	-	-	-	-	-
FCF per Share	-0.00	-	-	-	-	-	-	-	-	-	-	-
FCF Conversion (FCF/Net Income)	0.00x	-	-	-	-	-	-	-	-	-	-	-
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0

NRSN Cash Flow Statement